Logo image of CAMT

CAMTEK LTD (CAMT) Stock Fundamental Analysis

NASDAQ:CAMT - Nasdaq - IL0010952641 - Common Stock - Currency: USD

90.95  +3 (+3.41%)

After market: 90.95 0 (0%)

Fundamental Rating

6

Taking everything into account, CAMT scores 6 out of 10 in our fundamental rating. CAMT was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. CAMT scores excellent on profitability, but there are some minor concerns on its financial health. CAMT is valued quite expensive, but it does show an excellent growth. These ratings would make CAMT suitable for growth investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CAMT had positive earnings in the past year.
CAMT had positive earnings in each of the past 5 years.
CAMT had a positive operating cash flow in each of the past 5 years.
CAMT Yearly Net Income VS EBIT VS OCF VS FCFCAMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

CAMT's Return On Assets of 13.67% is amongst the best of the industry. CAMT outperforms 84.55% of its industry peers.
The Return On Equity of CAMT (21.72%) is better than 88.18% of its industry peers.
CAMT's Return On Invested Capital of 13.44% is amongst the best of the industry. CAMT outperforms 84.55% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CAMT is in line with the industry average of 10.58%.
The last Return On Invested Capital (13.44%) for CAMT is above the 3 year average (11.43%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.67%
ROE 21.72%
ROIC 13.44%
ROA(3y)11.71%
ROA(5y)10.6%
ROE(3y)19.67%
ROE(5y)17.82%
ROIC(3y)11.43%
ROIC(5y)11.2%
CAMT Yearly ROA, ROE, ROICCAMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

CAMT's Profit Margin of 28.32% is amongst the best of the industry. CAMT outperforms 89.09% of its industry peers.
In the last couple of years the Profit Margin of CAMT has grown nicely.
With an excellent Operating Margin value of 26.72%, CAMT belongs to the best of the industry, outperforming 86.36% of the companies in the same industry.
In the last couple of years the Operating Margin of CAMT has grown nicely.
CAMT has a better Gross Margin (50.34%) than 60.91% of its industry peers.
CAMT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.72%
PM (TTM) 28.32%
GM 50.34%
OM growth 3Y-0.13%
OM growth 5Y9.82%
PM growth 3Y7.46%
PM growth 5Y11.08%
GM growth 3Y-0.69%
GM growth 5Y0.63%
CAMT Yearly Profit, Operating, Gross MarginsCAMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CAMT is still creating some value.
Compared to 1 year ago, CAMT has more shares outstanding
The number of shares outstanding for CAMT has been increased compared to 5 years ago.
CAMT has a better debt/assets ratio than last year.
CAMT Yearly Shares OutstandingCAMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CAMT Yearly Total Debt VS Total AssetsCAMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 9.36 indicates that CAMT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 9.36, CAMT is in the better half of the industry, outperforming 74.55% of the companies in the same industry.
CAMT has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
CAMT has a Debt to Equity ratio of 0.34. This is in the lower half of the industry: CAMT underperforms 64.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 9.36
ROIC/WACC1.09
WACC12.34%
CAMT Yearly LT Debt VS Equity VS FCFCAMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 5.27 indicates that CAMT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.27, CAMT is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
A Quick Ratio of 4.26 indicates that CAMT has no problem at all paying its short term obligations.
CAMT has a better Quick ratio (4.26) than 76.36% of its industry peers.
Industry RankSector Rank
Current Ratio 5.27
Quick Ratio 4.26
CAMT Yearly Current Assets VS Current LiabilitesCAMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.50% over the past year.
The Earnings Per Share has been growing by 34.86% on average over the past years. This is a very strong growth
CAMT shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.65%.
Measured over the past years, CAMT shows a very strong growth in Revenue. The Revenue has been growing by 26.20% on average per year.
EPS 1Y (TTM)37.5%
EPS 3Y20.9%
EPS 5Y34.86%
EPS Q2Q%25.4%
Revenue 1Y (TTM)32.65%
Revenue growth 3Y16.74%
Revenue growth 5Y26.2%
Sales Q2Q%22.29%

3.2 Future

CAMT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.04% yearly.
Based on estimates for the next years, CAMT will show a quite strong growth in Revenue. The Revenue will grow by 16.16% on average per year.
EPS Next Y16.18%
EPS Next 2Y12.7%
EPS Next 3Y11.93%
EPS Next 5Y17.04%
Revenue Next Year14.48%
Revenue Next 2Y11.56%
Revenue Next 3Y11.08%
Revenue Next 5Y16.16%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CAMT Yearly Revenue VS EstimatesCAMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 200M 400M 600M 800M
CAMT Yearly EPS VS EstimatesCAMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 30.62 indicates a quite expensive valuation of CAMT.
Compared to the rest of the industry, the Price/Earnings ratio of CAMT indicates a somewhat cheap valuation: CAMT is cheaper than 66.36% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CAMT to the average of the S&P500 Index (27.19), we can say CAMT is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 25.48, the valuation of CAMT can be described as expensive.
Based on the Price/Forward Earnings ratio, CAMT is valued a bit cheaper than 60.91% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.33, CAMT is valued a bit cheaper.
Industry RankSector Rank
PE 30.62
Fwd PE 25.48
CAMT Price Earnings VS Forward Price EarningsCAMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CAMT.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 33.05
CAMT Per share dataCAMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CAMT does not grow enough to justify the current Price/Earnings ratio.
CAMT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.89
PEG (5Y)0.88
EPS Next 2Y12.7%
EPS Next 3Y11.93%

0

5. Dividend

5.1 Amount

CAMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CAMTEK LTD

NASDAQ:CAMT (7/15/2025, 8:00:02 PM)

After market: 90.95 0 (0%)

90.95

+3 (+3.41%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners53.69%
Inst Owner Change0%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap4.15B
Analysts84
Price Target86.81 (-4.55%)
Short Float %13.01%
Short Ratio8.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.33
Dividend Growth(5Y)56.87%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.81%
Min EPS beat(2)0.51%
Max EPS beat(2)1.1%
EPS beat(4)4
Avg EPS beat(4)2.1%
Min EPS beat(4)0.51%
Max EPS beat(4)6.06%
EPS beat(8)8
Avg EPS beat(8)3.66%
EPS beat(12)11
Avg EPS beat(12)2.6%
EPS beat(16)13
Avg EPS beat(16)2.67%
Revenue beat(2)0
Avg Revenue beat(2)-1.17%
Min Revenue beat(2)-2.27%
Max Revenue beat(2)-0.07%
Revenue beat(4)1
Avg Revenue beat(4)-0.42%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.23%
Revenue beat(12)2
Avg Revenue beat(12)-0.78%
Revenue beat(16)4
Avg Revenue beat(16)-0.5%
PT rev (1m)0%
PT rev (3m)-22.63%
EPS NQ rev (1m)-0.03%
EPS NQ rev (3m)1.15%
EPS NY rev (1m)-0.38%
EPS NY rev (3m)-0.4%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-1.44%
Valuation
Industry RankSector Rank
PE 30.62
Fwd PE 25.48
P/S 9.2
P/FCF N/A
P/OCF N/A
P/B 7.05
P/tB 8.26
EV/EBITDA 33.05
EPS(TTM)2.97
EY3.27%
EPS(NY)3.57
Fwd EY3.92%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS9.89
BVpS12.89
TBVpS11.01
PEG (NY)1.89
PEG (5Y)0.88
Profitability
Industry RankSector Rank
ROA 13.67%
ROE 21.72%
ROCE 14.95%
ROIC 13.44%
ROICexc 13.44%
ROICexgc 15.04%
OM 26.72%
PM (TTM) 28.32%
GM 50.34%
FCFM N/A
ROA(3y)11.71%
ROA(5y)10.6%
ROE(3y)19.67%
ROE(5y)17.82%
ROIC(3y)11.43%
ROIC(5y)11.2%
ROICexc(3y)23.25%
ROICexc(5y)34.93%
ROICexgc(3y)26.06%
ROICexgc(5y)36.79%
ROCE(3y)12.71%
ROCE(5y)12.46%
ROICexcg growth 3Y-39.43%
ROICexcg growth 5Y-18.22%
ROICexc growth 3Y-41.68%
ROICexc growth 5Y-20%
OM growth 3Y-0.13%
OM growth 5Y9.82%
PM growth 3Y7.46%
PM growth 5Y11.08%
GM growth 3Y-0.69%
GM growth 5Y0.63%
F-ScoreN/A
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 1.51
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.27
Quick Ratio 4.26
Altman-Z 9.36
F-ScoreN/A
WACC12.34%
ROIC/WACC1.09
Cap/Depr(3y)145.49%
Cap/Depr(5y)140.52%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.15%
Profit Quality(3y)82.13%
Profit Quality(5y)89.36%
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3Y20.9%
EPS 5Y34.86%
EPS Q2Q%25.4%
EPS Next Y16.18%
EPS Next 2Y12.7%
EPS Next 3Y11.93%
EPS Next 5Y17.04%
Revenue 1Y (TTM)32.65%
Revenue growth 3Y16.74%
Revenue growth 5Y26.2%
Sales Q2Q%22.29%
Revenue Next Year14.48%
Revenue Next 2Y11.56%
Revenue Next 3Y11.08%
Revenue Next 5Y16.16%
EBIT growth 1Y62.24%
EBIT growth 3Y16.58%
EBIT growth 5Y38.59%
EBIT Next Year23.41%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.63%
FCF growth 3Y25.41%
FCF growth 5Y36.93%
OCF growth 1Y53.8%
OCF growth 3Y26.02%
OCF growth 5Y37.72%